4.6 Article

Sick Leave and Disability Pension in Prevalent Patients With Crohn's Disease

Journal

JOURNAL OF CROHNS & COLITIS
Volume 12, Issue 12, Pages 1418-1428

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjy123

Keywords

Crohn's disease; sick leave; disability pension; work disability; inflammatory bowel disease

Funding

  1. Karolinska Institutet
  2. Swedish Society of Medicine (The Bengt Ihre Research Foundation) Stiftelsen Tornspiran
  3. Mag-tarmfonden
  4. Swedish Research Council-Medicine
  5. Swedish Cancer Society
  6. Swedish Foundation for Strategic Research
  7. Stockholm County Council (ALF project)
  8. National Institutes of Health

Ask authors/readers for more resources

Background and Aims: Crohn's disease may affect the ability to work and lead to permanent disability. We aimed to investigate work loss in prevalent patients. Methods: We identified patients with Crohn's disease and general population comparators matched by sex, birth year, healthcare region and education. We assessed days of sick leave and disability pension retrieved from the Swedish Social Insurance Agency and estimated the absolute and relative risk of receiving disability pension [minimum 25% work impairment]. Results: In 2014, the 20 638 Crohn's disease patients [median age 44 years] had more than twice as many mean lost workdays [disability pension: 44; sick leave: 19] as the 102 038 comparators [disability pension: 20; sick leave: 8], mean difference 35 days [95% confidence interval 33-37]. However, the majority had no lost workdays [68% of patients and 85% of comparators]. The proportion of patients receiving disability pension was 15% (6.5% in the comparators, risk ratio 2.34 [2.25-2.43]) and was higher in all subgroups, especially in female patients [28% vs 13% in the comparators], in those with <= 9 years of education [41% vs 23%] and in ages 60-64 years [46% vs 25%]. The relative risk of disability pension within the patient cohort [adjusted for age, sex, region and education] was higher in patients with complicated disease behaviour, extraintestinal manifestations, need of surgery or treatment with biologics. The differences between patients and comparators remained when comparing other calendar years [2006-2013]. Conclusion: Work loss was found in approximately one-third of patients. The mean number of lost workdays was twice as high as in the comparators.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease

Anders Forss, Mark Clements, Par Myrelid, Hans Strid, Charlotte Soderman, Agnieszka Wagner, David Andersson, Fredrik Hjelm, Ola Olen, Jonas Halfvarson, Jonas F. Ludvigsson

Summary: This study demonstrates the long-term clinical effectiveness of ustekinumab in patients with active Crohn's disease, as well as its improvement in Health-related Quality of Life (HRQoL) measures.

DIGESTIVE DISEASES AND SCIENCES (2023)

Article Oncology

Cancer risk in patients with diverticular disease: A nationwide cohort study

Wenjie Ma, Marjorie M. Walker, Marcus Thuresson, Bjorn Roelstraete, Filip Skoldberg, Ola Olen, Lisa L. Strate, Andrew T. Chan, Jonas F. Ludvigsson

Summary: This study found that patients with diverticular disease who have colorectal histopathology have a 33% increased risk of overall incident cancer, with specific increases in colon, liver, pancreatic, and lung cancers.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Gastroenterology & Hepatology

Bidirectional Mendelian Randomisation Analysis Provides Evidence for the Causal Involvement of Dysregulation of CXCL9, CCL11 and CASP8 in the Pathogenesis of Ulcerative Colitis

Jie Chen, Yajing Zhou, Yuhao Sun, Shuai Yuan, Rahul Kalla, Jing Sun, Jianhui Zhao, Lijuan Wang, Xuejie Chen, Xuan Zhou, Siqi Dai, Yu Zhang, Gwo-tzer Ho, Dajing Xia, Qian Cao, Zhanju Liu, Susanna C. Larsson, Xiaoyan Wang, Kefeng Ding, Jonas Halfvarson, Xue Li, Evropi Theodoratou, Jack Satsangi

Summary: This study identified 14 proteins associated with the risk of ulcerative colitis (UC) through the analysis of serum proteomic profiling data. Further analysis using Mendelian randomisation confirmed the causal relationship between two chemokines and the increased risk of UC. Additionally, a new protein associated with UC risk was identified. Reverse Mendelian randomisation analysis did not find any influence of genetic predisposition to UC on these three inflammation proteins.

JOURNAL OF CROHNS & COLITIS (2023)

Article Rheumatology

The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017

Sofia Exarchou, Johan K. Wallman, Daniela Di Giuseppe, Eva Klingberg, Valgerdur Sigurdardottir, Sara Wedren, Ulf Lindstrom, Carl Turesson, Lennart T. H. Jacobsson, Johan Askling

Summary: This study aimed to estimate the prevalence of clinically diagnosed Psoriatic Arthritis (PsA) in Sweden in 2017 and assess the use of disease-modifying antirheumatic drugs (DMARDs) among PsA patients in contact with specialized rheumatology care. The prevalence of PsA in Sweden was approximately 0.35% among adults aged 18 to 79 years in 2017, and nearly three-fourths of PsA patients in recent contact with specialized rheumatology care received DMARD therapy in 2017.

JOURNAL OF RHEUMATOLOGY (2023)

Article Medicine, Research & Experimental

Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods

Hilde Berner Hammer, Sigve Lans Pedersen, Maria K. K. Jonsson, Linda Mathsson-Alm, Isabel Gehring, Joe Sexton, Espen A. A. Haavardsholm, Johan Askling

Summary: This study compared two different laboratory methods for assessing calprotectin in plasma samples from patients with early or established rheumatoid arthritis (RA). The results showed high correlations between the two methods and similar correlations with clinical examinations. The study supports the robustness of calprotectin analyses and suggests its inclusion in assessments offered by clinical routine laboratories.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2023)

Article Medicine, General & Internal

Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden

Jiangwei Sun, Fang Fang, Ola Olen, Mingyang F. Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Jonas Ludvigsson

Summary: In this study, individuals who underwent endoscopic biopsy with normal mucosa were followed up for a median of 10 years. The study found that these individuals had an elevated risk of inflammatory bowel disease (IBD) for at least 30 years. These findings imply the presence of a substantial symptomatic period before the diagnosis of IBD and emphasize the importance of considering the long-term risk of IBD in patients with symptoms but normal mucosa on gastrointestinal investigation.

PLOS MEDICINE (2023)

Article Gastroenterology & Hepatology

Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis

Aiva Lundberg Bave, Ola Olen, Jonas Soederling, Jonas F. Ludvigsson, Annika Bergquist, Caroline Nordenvall

Summary: Colectomy in UC patients was not associated with a decreased risk of subsequent PSC. The observed differences in the risk of PSC development over calendar periods are likely due to changes in PSC-diagnosis and UC-treatment.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

Correction Public, Environmental & Occupational Health

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden (vol 13, pg 21, 2021)

J. F. Ludvigsson, P. Appelros, J. Askling

CLINICAL EPIDEMIOLOGY (2023)

Article Rheumatology

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study

Ulf Lindstrom, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K. Wallman

Summary: This study aimed to compare the treatment outcomes of patients with newly diagnosed psoriatic arthritis (PsA) and rheumatoid arthritis (RA) using methotrexate (MTX) monotherapy. The results showed that PsA patients were less likely to continue the use of MTX compared to RA patients, and the effectiveness of MTX was also lower in PsA.

RMD OPEN (2023)

Article Gastroenterology & Hepatology

Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population-based matched cohort study

David Bergman, Bjorn Roelstraete, Jiangwei Sun, Fahim Ebrahimi, Johan Askling, Jonas F. Ludvigsson

Summary: A study found that there is an association between microscopic colitis (MC) and rheumatoid arthritis (RA), with MC patients being nearly twice as likely to develop RA compared to the general population. This study is important as it highlights the need for expedited evaluation for RA in MC patients presenting with joint symptoms and/or arthralgia, thus preventing delay in RA diagnosis.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case-control study

Kyle Staller, Ola Olen, Jonas Soderling, Bjorn Roelstraete, Hans Tornblom, Braden Kuo, Long H. Nguyen, Jonas F. Ludvigsson

Summary: The study found that previous use of antibiotics was associated with an increased risk of developing irritable bowel syndrome (IBS), particularly among those with multiple antibiotic dispensations.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Medicine, General & Internal

Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study

Jiangwei Sun, Bjorn Roelstraete, Emma Svennberg, Jonas Halfvarson, Johan Sundstrom, Anders Forss, Ola Olen, Jonas F. Ludvigsson

Summary: This study found that patients with inflammatory bowel disease (IBD) have an increased risk of developing arrhythmias. This increased risk persists even 25 years after the diagnosis of IBD.

PLOS MEDICINE (2023)

Article Gastroenterology & Hepatology

Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease

Archana Shubhakar, Bas C. Jansen, Alex T. Adams, Karli R. Reiding, Nicholas T. Ventham, Rahul Kalla, Daniel Bergemalm, Paulina A. Urbanowicz, Richard A. Gardner, Manfred IBD BIOM Consortium, Manfred Wuhrer, Jonas Halfvarson, Jack Satsangi, Daryl L. Fernandes, Daniel I. R. Spencer

Summary: This study investigated a composite serum N-glycomic biomarker to predict future disease course in newly diagnosed IBD patients. The biomarker showed a predictive capacity for treatment escalation in both the discovery and replication cohorts of patients.

JOURNAL OF CROHNS & COLITIS (2023)

Article Gastroenterology & Hepatology

Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort

Amiko M. Uchida, John J. Garber, Ashley Pyne, Kathryn Peterson, Bjorn Roelstraete, Ola Olen, Jonas Halfvarson, Jonas F. Ludvigsson

Summary: In this nationwide cohort study, EoE was found to be associated with a 3.5-fold increased risk of later IBD diagnosis, possibly due to genetic or early environmental risk factors.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

Meeting Abstract Gastroenterology & Hepatology

ECONOMIC BURDEN OF EOSINOPHILIC ESOPHAGITIS: A NATIONWIDE COST-OF-ILLNESS STUDY ENCOMPASSING COSTS FOR HEALTH CARE USE AND PRODUCTIVITY LOSSES

Soran Rabin Bozorg, Jonas Soderling, Karl Marild, John J. Garber, Amiko M. Uchida, Martin Neovius, Jonas F. Ludvigsson, Asa H. Everhov

GASTROENTEROLOGY (2023)

No Data Available